Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

CLRB US Equity

Cellectar Biosciences, Inc.Health Care · Pharmaceutical Preparations · CIK 1279704 · FY ends Dec 31
$2.62
+0.03 (+1.16%)
USD · as of 2026-08-19 · marketstack
2 8-K filings · 0 13D · 6 13G
DateEventWhat happened / filerSource
2026-08-1413GSchedule 13G filed — ≥5% beneficial owner (passive) · by Caligan Partners LPsec.gov ↗
2026-08-1413GSchedule 13G filed — ≥5% beneficial owner (passive) · by SILVERARC CAPITAL MANAGEMENT, LLCsec.gov ↗
2026-08-1413GSchedule 13G filed — ≥5% beneficial owner (passive) · by STEMPOINT CAPITAL LPsec.gov ↗
2026-08-1413GSchedule 13G filed — ≥5% beneficial owner (passive) · by BALYASNY ASSET MANAGEMENT L.P.sec.gov ↗
2026-08-1313GSchedule 13G filed — ≥5% beneficial owner (passive) · by Bleichroeder LPsec.gov ↗
2026-08-138-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-08-0413GSchedule 13G filed — ≥5% beneficial owner (passive) · by Empery Asset Management, LPsec.gov ↗
2026-07-108-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-07-108-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-10

Every row is a filed document, checked against its EDGAR index.